Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

YUKA1

😃Good
Catalog No. T17278Cas No. 708991-09-7
Alias YUKA 1

YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 μM) with a weak effect on KDM5C (IC50=7.12 μM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells.

YUKA1

YUKA1

😃Good
Purity: 99.85%
Catalog No. T17278Alias YUKA 1Cas No. 708991-09-7
YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 μM) with a weak effect on KDM5C (IC50=7.12 μM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$113-In Stock
5 mg$278-In Stock
10 mg$455-In Stock
25 mg$892-In Stock
50 mg$1,360-In Stock
100 mg$1,980-In Stock
200 mg$2,730-In Stock
1 mL x 10 mM (in DMSO)$297-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 μM) with a weak effect on KDM5C (IC50=7.12 μM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells.
In vitro
YUKA1 selectively inhibits NEK2 autophosphorylation in human cancer cell lines (e.g., MDA-MB-231, BT20, MCF7), leading to mitotic arrest, spindle defects, polyploidy, and increased apoptosis at 10-30 μM (24-48 h). YUKA1 also enhances paclitaxel sensitivity[1].
SynonymsYUKA 1
Chemical Properties
Molecular Weight292.36
FormulaC13H16N4O2S
Cas No.708991-09-7
SmilesS=C1NN=CN1NCC=2C=CC=C(OC)C2OCC=C
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (273.64 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4204 mL17.1022 mL34.2044 mL171.0220 mL
5 mM0.6841 mL3.4204 mL6.8409 mL34.2044 mL
10 mM0.3420 mL1.7102 mL3.4204 mL17.1022 mL
20 mM0.1710 mL0.8551 mL1.7102 mL8.5511 mL
50 mM0.0684 mL0.3420 mL0.6841 mL3.4204 mL
100 mM0.0342 mL0.1710 mL0.3420 mL1.7102 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy YUKA1 | purchase YUKA1 | YUKA1 cost | order YUKA1 | YUKA1 chemical structure | YUKA1 in vitro | YUKA1 formula | YUKA1 molecular weight